Drug intelligence / Profile preview

bupivacaine + epinephrine

Development stage
Approved
Lead developer
Pfizer
Modality
Small Molecules
Administration
Infiltration, Epidural, Caudal, Peripheral Nerve Block, Dental
01

Overview

**Bupivacaine + epinephrine** is a fixed-dose injectable combination of the long-acting amide local anesthetic bupivacaine hydrochloride and the vasoconstrictor epinephrine, commonly supplied with epinephrine 1:200,000. Bupivacaine reversibly inhibits voltage-gated sodium channels in peripheral nerves, preventing initiation and propagation of nerve impulses. Epinephrine activates adrenergic receptors, with local alpha-1-mediated vasoconstriction reducing local blood flow, slowing systemic absorption of bupivacaine, prolonging anesthesia, and reducing peak systemic exposure. It is used in adults to produce local or regional anesthesia and analgesia for surgical, dental, diagnostic, therapeutic, and obstetrical procedures through infiltration, peripheral nerve block, caudal block, and epidural block. ([dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=67578b56-7540-487e-1fba-481255620e78))

Brand names
Marcaine/EpinephrineMarcaine/Epinephrine PFSensorcaine-MPF/EPINEPHrineSensorcaine/EPINEPHrineVivacaine
Other names
bupivacaine + adrenalinebupivacaine + epinephrinebupivacaine hydrochloride + epinephrinebupivacaine hydrochloride + epinephrine bitartratebupivacaine HCl + epinephrinebupivacaine HCl + epinephrine bitartrate
02

Targets

ADRA1 (Alpha-1 adrenergic receptor family)ADRB1 (β1)NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on bupivacaine + epinephrine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on bupivacaine + epinephrine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call